H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Census population 204,851. Florida Medicare wound biologics: First Coast Service Options (JN). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Port St. Lucie clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Port St. Lucie storefront.
Growth Factor Therapy for Tissue Repair in Port St. Lucie, FL for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
Adult obesity in Port St. Lucie is 30.5% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. CDC PLACES (2023, crude) estimates 13.1% of adults in Port St. Lucie have diagnosed diabetes — 1.1 points above the U.S. 12% figure. Florida includes CDC Diabetes Belt counties, so DFU planning belongs in the annual budget. Hawk Medical is the distributor for growth factor therapy, not a walk-in clinic.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)JN reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Port St. Lucie is 13.1% or not. PLACES is planning data. The LCD is the claim.
We are not going to invent a Port St. Lucie warehouse or a five-star local review. What you get is growth factor therapy from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JN, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 13.1% of adults — 1.1 points above the U.S. 12% figure. Obesity is 30.5%; arthritis is 27.9%. That is place-level BRFSS modeling, not a clinic census and not a Port St. Lucie trial.
Yes — receiving, storage, indication, and documentation templates are part of onboarding. SOPs still have to be adopted as the clinic’s own procedures; we do not pretend to be the medical director in Port St. Lucie.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Ask for the IFU, the lot-traceability packet, and the First Coast Service Options article IDs for the codes you actually bill. If the sales sheet cannot produce those, do not put it in a Port St. Lucie fridge. That is how an account with us starts.
Contact us to learn how Hawk Medical supports practices in Port St. Lucie, FL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Port St. Lucie is JN geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Port St. Lucie — 1.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Florida Part B wound biologics follow this contractor (siblings: no other states). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Port St. Lucie. Useful for joint-program math; still needs a diagnosis and privileging.
No Port St. Lucie storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.